Avacta Group plc (AIM: AVCT), a clinical stage oncology company and developer of powerful diagnostics based on its innovative Affimer® and pre|CISION™ platforms, will announce its financial results for the year ended 31 December 2021 on Wednesday, 6 April 2022.
Investor webinar
An investor webinar presentation by Alastair Smith, Chief Executive Officer and Tony Gardiner, Chief Financial Officer will take place at 11:00am BST on Wednesday, 6 April 2022.
The webinar is open to all existing and potential investors and will consist of a presentation followed by a Q&A session, held on the Investor Meet Company platform. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and then click “Add to meet” Avacta Group via the following link to join the webinar:
https://www.investormeetcompany.com/avacta-group-plc/register-investor
Investors who already follow Avacta Group plc on the Investor Meet Company platform will automatically be invited.
The Company will also post its results presentation on its website at the following page: https://avacta.com/investors/documents-presentations.